EMD-25451

Single-particle
30.0 Å
EMD-25451 Deposition: 19/11/2021
Map released: 22/12/2021
Last modified: 22/12/2021
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-25451

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

pCoV111, a Ferritin-based Nanoparticle Vaccine Candidate Displaying the SARS-CoV-2 Spike S1 Subunit

EMD-25451

Single-particle
30.0 Å
EMD-25451 Deposition: 19/11/2021
Map released: 22/12/2021
Last modified: 22/12/2021
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: pCoV111, a Ferritin-based Nanoparticle Vaccine Candidate Displaying the SARS-CoV-2 Spike S1 Subunit

Deposition Authors: Thomas PV , Smith C , Chen WH , Sankhala RS , Hajduczki A , Choe M , Martinez E , Chang W , Peterson CE , Karch C , Gohain N , Kannadka CB , de Val N , Joyce MG , Modjarrad K
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity